Literature DB >> 19099296

Glutamatergic and GABAergic modulations of ultrasonic vocalizations during maternal separation distress in mouse pups.

Aki Takahashi1, Jasmine J Yap, Dawnya Zitzman Bohager, Sara Faccidomo, Terry Clayton, James M Cook, Klaus A Miczek.   

Abstract

INTRODUCTION: Dysregulation of GABAergic inhibition and glutamatergic excitation has been implicated in exaggerated anxiety. Mouse pups emit distress-like ultrasonic vocalizations (USVs) when they are separated from their dam/siblings, and this behavior is reduced by benzodiazepines (BZs) which modulate GABAergic inhibition. The roles of glutamate receptors on USVs remain to be investigated.
MATERIALS AND METHODS: We examined the roles of glutamate receptor subtypes on mouse pup USVs using N-methyl-D: -aspartate (NMDA) receptor antagonists with different affinities [dizocilpine (MK-801), memantine, and neramexane] and group II metabotropic glutamate receptor agonist (LY-379268) and antagonist (LY-341495). These effects were compared with classic BZs: flunitrazepam, bromazepam, and chlordiazepoxide. To assess the role of GABA(A) receptor subunits on USVs, drugs that have preferential actions at different GABA(A)-alpha subunits (L-838417 and QH-ii-066) were tested. Seven-day-old CFW mouse pups were separated from their dam and littermates and placed individually on a 19 degrees C test platform for 4 min. Grid crossings and body rolls were measured in addition to USVs.
RESULTS: Dizocilpine dose-dependently reduced USVs, whereas memantine and neramexane showed biphasic effects and enhanced USVs at low to moderate doses. The NMDA receptor antagonists increased locomotion. LY-379268 reduced USVs but also suppressed locomotion. All BZs reduced USVs and increased motor incoordination. Neither L-838417 nor QH-ii-066 changed USVs, but both induced motor incoordination.
CONCLUSION: Low-affinity NMDA receptor antagonists, but not the high-affinity antagonist, enhanced mouse pup distress calls, which may be reflective of an anxiety-like state. BZs reduced USVs but also induced motor incoordination, possibly mediated by the alpha5 subunit containing GABA(A) receptors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19099296      PMCID: PMC2758424          DOI: 10.1007/s00213-008-1437-8

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  79 in total

1.  Pharmacophore/receptor models for GABA(A)/BzR subtypes (alpha1beta3gamma2, alpha5beta3gamma2, and alpha6beta3gamma2) via a comprehensive ligand-mapping approach.

Authors:  Q Huang; X He; C Ma; R Liu; S Yu; C A Dayer; G R Wenger; R McKernan; J M Cook
Journal:  J Med Chem       Date:  2000-01-13       Impact factor: 7.446

2.  Excitatory transmission in the basolateral amygdala.

Authors:  D G Rainnie; E K Asprodini; P Shinnick-Gallagher
Journal:  J Neurophysiol       Date:  1991-09       Impact factor: 2.714

3.  Inhibition of the alpha9alpha10 nicotinic cholinergic receptor by neramexane, an open channel blocker of N-methyl-D-aspartate receptors.

Authors:  Paola V Plazas; Jessica Savino; Sebastian Kracun; María E Gomez-Casati; Eleonora Katz; Christopher G Parsons; Neil S Millar; Ana B Elgoyhen
Journal:  Eur J Pharmacol       Date:  2007-03-24       Impact factor: 4.432

4.  Evidence for a significant role of alpha 3-containing GABAA receptors in mediating the anxiolytic effects of benzodiazepines.

Authors:  Rebecca Dias; Wayne F A Sheppard; Rosa L Fradley; Elizabeth M Garrett; Joanna L Stanley; Spencer J Tye; Simon Goodacre; Rachael J Lincoln; Susan M Cook; Rachel Conley; David Hallett; Alexander C Humphries; Sally A Thompson; Keith A Wafford; Leslie J Street; J Luis Castro; Paul J Whiting; Thomas W Rosahl; John R Atack; Ruth M McKernan; Gerard R Dawson; David S Reynolds
Journal:  J Neurosci       Date:  2005-11-16       Impact factor: 6.167

Review 5.  Metabotropic glutamate receptors as novel targets for anxiety and stress disorders.

Authors:  Chad J Swanson; Mark Bures; Michael P Johnson; Anni-Maija Linden; James A Monn; Darryle D Schoepp
Journal:  Nat Rev Drug Discov       Date:  2005-02       Impact factor: 84.694

6.  Different GABAA receptor subtypes mediate the anxiolytic, abuse-related, and motor effects of benzodiazepine-like drugs in primates.

Authors:  James K Rowlett; Donna M Platt; Snjezana Lelas; John R Atack; Gerard R Dawson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-11       Impact factor: 11.205

7.  Switch in the expression of rat GABAA-receptor subtypes during postnatal development: an immunohistochemical study.

Authors:  J M Fritschy; J Paysan; A Enna; H Mohler
Journal:  J Neurosci       Date:  1994-09       Impact factor: 6.167

8.  Hypothermic vocalizations of rat pups (Rattus norvegicus) elicit and direct maternal search behavior.

Authors:  S A Brunelli; H N Shair; M A Hofer
Journal:  J Comp Psychol       Date:  1994-09       Impact factor: 2.231

9.  Memantine acts as a cholinergic stimulant in the mouse hippocampus.

Authors:  Benjamin D Drever; William G L Anderson; Helena Johnson; Matthew O'Callaghan; Sangwon Seo; Deog-Young Choi; Gernot Riedel; Bettina Platt
Journal:  J Alzheimers Dis       Date:  2007-12       Impact factor: 4.472

Review 10.  Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system--too little activation is bad, too much is even worse.

Authors:  Chris G Parsons; Albrecht Stöffler; Wojciech Danysz
Journal:  Neuropharmacology       Date:  2007-08-10       Impact factor: 5.250

View more
  13 in total

1.  Lrfn2-Mutant Mice Display Suppressed Synaptic Plasticity and Inhibitory Synapse Development and Abnormal Social Communication and Startle Response.

Authors:  Yan Li; Ryunhee Kim; Yi Sul Cho; Woo Seok Song; Doyoun Kim; Kyungdeok Kim; Junyeop Daniel Roh; Changuk Chung; Hanwool Park; Esther Yang; Soo-Jeong Kim; Jaewon Ko; Hyun Kim; Myoung-Hwan Kim; Yong-Chul Bae; Eunjoon Kim
Journal:  J Neurosci       Date:  2018-05-24       Impact factor: 6.167

2.  Reduced scent marking and ultrasonic vocalizations in the BTBR T+tf/J mouse model of autism.

Authors:  M Wöhr; F I Roullet; J N Crawley
Journal:  Genes Brain Behav       Date:  2011-02       Impact factor: 3.449

3.  The fetal brain transcriptome and neonatal behavioral phenotype in the Ts1Cje mouse model of Down syndrome.

Authors:  Faycal Guedj; Jeroen L A Pennings; Millie A Ferres; Leah C Graham; Heather C Wick; Klaus A Miczek; Donna K Slonim; Diana W Bianchi
Journal:  Am J Med Genet A       Date:  2015-05-14       Impact factor: 2.802

4.  Developmental delays and reduced pup ultrasonic vocalizations but normal sociability in mice lacking the postsynaptic cell adhesion protein neuroligin2.

Authors:  Markus Wöhr; Jill L Silverman; Maria L Scattoni; Sarah M Turner; Mark J Harris; Roheeni Saxena; Jacqueline N Crawley
Journal:  Behav Brain Res       Date:  2012-07-20       Impact factor: 3.332

5.  Atp13a2 expression in the periaqueductal gray is decreased in the Pink1 -/- rat model of Parkinson disease.

Authors:  Cynthia A Kelm-Nelson; Sharon A Stevenson; Michelle R Ciucci
Journal:  Neurosci Lett       Date:  2016-04-04       Impact factor: 3.046

6.  Serotonin deficiency alters susceptibility to the long-term consequences of adverse early life experience.

Authors:  Benjamin D Sachs; Ramona M Rodriguiz; Ha L Tran; Akshita Iyer; William C Wetsel; Marc G Caron
Journal:  Psychoneuroendocrinology       Date:  2015-01-06       Impact factor: 4.905

7.  The metabotropic glutamate 2/3 receptor agonist LY379268 induces anxiety-like behavior at the highest dose tested in two rat models of anxiety.

Authors:  Vasilios Grivas; Athina Markou; Nikolaos Pitsikas
Journal:  Eur J Pharmacol       Date:  2013-06-11       Impact factor: 4.432

8.  A Novel Chd8 Mutant Mouse Displays Altered Ultrasonic Vocalizations and Enhanced Motor Coordination.

Authors:  Samuel W Hulbert; Xiaoming Wang; Simisola O Gbadegesin; Qiong Xu; Xiu Xu; Yong-Hui Jiang
Journal:  Autism Res       Date:  2020-08-19       Impact factor: 5.216

9.  Using an experimental medicine model to understand the antidepressant potential of the N-Methyl-D-aspartic acid (NMDA) receptor antagonist memantine.

Authors:  A Pringle; E Parsons; L G Cowen; S F McTavish; P J Cowen; C J Harmer
Journal:  J Psychopharmacol       Date:  2012-05-16       Impact factor: 4.153

10.  Communication impairments in mice lacking Shank1: reduced levels of ultrasonic vocalizations and scent marking behavior.

Authors:  Markus Wöhr; Florence I Roullet; Albert Y Hung; Morgan Sheng; Jacqueline N Crawley
Journal:  PLoS One       Date:  2011-06-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.